Orchid Pharma P/E Ratio

Current P/E Ratio
556.34
High Valuation
Very High - High growth expectations or significantly overvalued

Orchid Pharma P/E ratio. Orchid Pharma (ORCHPHARMA) P/E ratio is 556.34 (High), EPS (TTM) ₹1.66, current price ₹965.90 on NSE vs historical average P/E of 23.41 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Examine ORCHPHARMA quarterly results for recent quarterly revenue, profit and EPS trends.

Current Valuation Metrics

P/E Ratio 556.34
Current Price ₹965.90
EPS (TTM) ₹1.66
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 23.41
Historical Range 13.77 - 33.04
Percentile 100.0%

Sector Context

Sector Average 53.75
Sector Median 31.61
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹8.12
Mar 2026 ₹4.31
Jun 2026 ₹0.54

ORCHPHARMA P/E Ratio — Valuation Signal & Historical Context

Orchid Pharma P/E 556.34 vs historical average 23.41, range 13.77–33.04 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see ORCHPHARMA stock price BSE.

  • Stock appears overvalued with PE of 556.34, suggesting caution for new investments
  • Current PE is 2277.0% above historical average
  • Trading at premium to sector average PE of 53.75

Orchid Pharma P/E Ratio Historical Trend

ORCHPHARMA annual price-to-earnings ratio — 2 years, EPS and year-end price. Current P/E 556.34 vs historical average 23.41. Also explore ORCHPHARMA share price charts to track price trends across different timeframes.

ORCHPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation

Orchid Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 33.04 22.07 ₹729.10 NSE High
2023 13.77 26.82 ₹369.40 NSE Low

ORCHPHARMA vs Healthcare Peers — P/E Ratio Comparison

Orchid Pharma P/E 556.34 vs Healthcare average 53.75, median 31.61 — range 2.04–740.29.

Sector Average
53.75
Sector Median
31.61
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low